Beta-blockers for heart failure
124 results
1 - 100
Beta-blockers for heart failure 
Beta‐blockers for congestive heart failure in children- Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
- Nurse‐led titration of angiotensin converting enzyme inhibitors, beta‐adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction
- Beta‐blockers in patients without heart failure after myocardial infarction
- Drug treatment for hypertension
Beta-blockers don't decrease mortality in patients with AF + CHF- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity
- Chronic heart failure
- Acute heart failure and pulmonary oedema
- Beta‐blockers for hypertension
- Perioperative beta-blockers = placebo for noncardiac surgery
- Beta-blockers in patients without heart failure after myocardial infarction
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Drugs for ventricular rate control in atrial fibrillation
- Heart failure nurse-led titration of heart failure medicines
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery
- Cardioselective beta‐blockers for reversible airway disease
- Drugs for chronic heart failure with preserved ejection fraction
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery
- Beta‐adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery
- Calcium channel blockers versus other classes of drugs for hypertension
- Chronic coronary syndrome (coronary heart disease)
- For patients with acute myocardial infarction and normal ejection fraction, beta-blockers did not improve cardiovascular outcomes (REBOOT-CNIC)
- Post-MI beta-blockers do not decrease mortality
- Hypertrophic cardiomyopathy
- Different antihypertensive agents as first line therapies
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
- Prevention of atrial fibrillation
- Phosphodiesterase III inhibitors for heart failure
- Management of acute atrial fibrillation
- Dilated cardiomyopathy
- Ventricular ectopic beats
- Digitalis for treatment of heart failure in patients in sinus rhythm
- Beta‐blockers for preventing aortic dissection in Marfan syndrome
- For patients with AMI and preserved ejection fraction, long-term beta-blockers do not improve outcomes (REDUCE-AMI)
- Calcium channel blockers versus other classes of drugs for hypertension
- Rate control in permanent atrial fibrillation
- The effect on ACE inhibitors on mortality and morbidity in patients with heart failure
- SGLT2 inhibitors optimal drug class for heart failure with preserved and mildly reduced ejection fraction
- BNP monitoring + protocol improves HF outcomes
- Exercise stress test
- First-line renin angiotensin system inhibitors versus other drug classes for hypertension
- Hypertension in elderly patients
- Choice of antihypertensive drug in the diabetic patient from prognostic point of view
- Acute heat illnesses
- aDrugs commonly causing poisonings
- Ventricular tachycardia
- BNP-guided therapy decreases heart failure mortality (BATTLESCARRED)
- Continued beta-blocker use after acute myocardial infarction (AMI) reduces hospitalizations but not cardiovascular death, AMI, or stroke
- Pharmacological interventions for heart failure in people with chronic kidney disease
- Diuretics for heart failure: Cochrane systematic review
- Digitoxin reduces composite of hospitalization for heart failure or all-cause mortality for patients with NYHA class III or IV heart failure (DIGIT-HF)
- Beta-blockers associated with improved morbidity/mortality in COPD patients
- Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation
- Hyperkalaemia
- Choice of prophylactic medication for atrial fibrillation - Image
- ACC/AHA guideline for the management of patients with chronic coronary disease
- Chronic diseases and pregnancy
- Aldosterone receptor antagonists spironolactone and eplerenone for congestive heart failure
- CV interventions in old elderly are not useful (DEBATE)
- The use of diltiazem, verapamil and short-acting nifedipine in heart failure
- Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD